1Desai SD and Blancchand J. Encyclopedia of Pharmaceutical Technology ( Swarbrick J and boylan JC. eds) [ M ].1995.43～ 47.
2Maurice D and Midhima S. Ocular pharmacokinetics: In Pharmacology of the Eye(M. Sears, ed)[ M]. 1984.19.
3Harris D and Robison JR. Bioadhesive polymers in peptide drug delivery[J]. Biomaterials, 1990,11:652.
4Robinson JR. Ocular drug delivery: Mechaism(s) of corneal drug tranport and mucoadhesive delivery systems[J ].S. T. P. Pharma, 1989,5:839.
5Mikos AG, PeppasNA. Systems for controlled release of drugs. V. Bioadhesive systems [ J ]. S. T. P. Pharm,1986,2: 705.
6Hui HW , Robison JR. Ocular delivery of progesterone using a bioadhesive polymer[J]. Int J Pharm, 1985,26:203.
7Gurny R ,Ibrahi H, et al. Design and evaluation of controlled release systems from the eye[J]. J controlled release, 1987,6: 367.
8Gurny R, BoyeT, IbraimH. Ocular therapy with nanoparticle systems for controlled drug delivery[J]. J controlled release, 1985,2: 353.
9Saettone MF, Chetoni P, et al. Evaluation of mucoadhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid[J]. Int J Pharm ,1989,51:203.
10Smart JL, Kellaway IW, Worthington HEC. Aninvivo investigation of mucosal adhesive materials for use in controlled drug delivery[J]. J Pharm Pharmacol, 1984,36:295.
